Gene testing for heart patients on clopidogrel in Egypt
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at how well your body processes clopidogrel (a blood thinner), based on your genes. It aims to see if certain gene changes affect how the medicine works for Egyptian patients after heart procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be Egyptian
- Have had a heart procedure (PCI) to open blocked arteries
- Had a heart attack (STEMI or NSTEMI) or unstable angina
- Are taking clopidogrel after your procedure
- Agree to provide a blood sample for genetic testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether choosing a shorter blood thinner treatment based on your genes, or reducing the dose, is safe and works well for people with high bleeding risk after getting a stent for a heart attack or chest pain.
This trial tests whether a genetic test can help doctors choose the best blood-thinning medicine for people with heart disease who are having a stent placed. The goal is to reduce the risk of blood clots or bleeding after the procedure.
This trial tests whether choosing a blood thinner based on your DNA can prevent more heart problems. If you've had a complex heart procedure, you may be able to get a medication that works best for your body.
This trial looks at whether using clopidogrel by itself (without aspirin) works for people after a new drug-eluting stent, based on a blood test of how your body processes the drug. It may help reduce “extra blood-thinning” if you have a certain genetic type that responds well to clopidogrel.
This study compares two blood-thinning medicines, aspirin and clopidogrel, to see which is better at preventing future heart problems in people with chronic coronary artery disease. If you have had a heart attack or unstable angina at least 6 months ago, this trial may help you understand an additional option for your heart health.
This trial tests whether using a rapid genetic test to choose antiplatelet medication can improve outcomes for people who have had a stroke or mini-stroke. The test checks a gene that affects how your body processes a common antiplatelet drug, so your doctors can pick the safest and most effective medicine for you.
Hear when a new Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.